当前位置: X-MOL 学术Cell. Signal. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Coordinated regulation of hepatic FoxO1, PGC-1α and SREBP-1c facilitates insulin action and resistance
Cellular Signalling ( IF 4.4 ) Pub Date : 2017-12-18 , DOI: 10.1016/j.cellsig.2017.12.005
Mini P. Sajan , Mackenzie C. Lee , Fabienne Foufelle , Joshua Sajan , Courtney Cleland , Robert V. Farese

Type 2 diabetes is characterized by insulin resistance, hyperinsulinemia and hepatic overproduction of glucose and lipids. Insulin increases lipogenic enzyme expression by activating Akt and aPKC which activate SREBP-1c; this pathway is hyperactivated in insulin-resistant states. Insulin suppresses gluconeogenic enzyme expression by Akt-dependent phosphorylation/inactivation of FoxO1 and PGC-1α; this pathway is impaired in insulin-resistant states by aPKC excess, which displaces Akt from scaffolding-protein WD40/ProF, where Akt phosphorylates/inhibits FoxO1. But how PGC-1α and FoxO1 are coordinated in insulin action and resistance is uncertain. Here, in normal mice, we found, along with Akt and aPKC, insulin increased PGC-1α association with WD40/ProF by an aPKC-dependent mechanism. However, in insulin-resistant high-fat-fed mice, like FoxO1, PGC-1α phosphorylation was impaired by aPKC-mediated displacement of Akt from WD40/ProF, as aPKC inhibition diminished its association with WD40/ProF, and simultaneously restored Akt association with WD40/ProF and phosphorylation/inhibition of both PGC-1α and FoxO1. Moreover, in high-fat-fed mice, in addition to activity, PGC-1α expression was increased, not only by FoxO1 activation, but also, as found in human hepatocytes, by a mechanism requiring aPKC and SREBP-1c, which also increased expression and activity of PKC-ι. In high-fat-fed mice, inhibition of hepatic aPKC, not only restored Akt association with WD40/ProF and FoxO1/PGC-1α phosphorylation, but also diminished expression of SREBP-1c, PGC-1α, PKC-ι and gluconeogenic and lipogenic enzymes, and corrected glucose intolerance and hyperlipidemia. Conclusion: Insulin suppression of gluconeogenic enzyme expression is facilitated by coordinated inactivation of FoxO1 and PGC-1α by WD40/ProF-associated Akt; but this coordination also increases vulnerability to aPKC hyperactivity, which is abetted by SREBP-1c-induced increases in PGC-1α and PKC-ι.



中文翻译:

肝FoxO1,PGC-1α和SREBP-1c的协调调节促进胰岛素作用和抵抗

2型糖尿病的特征是胰岛素抵抗,高胰岛素血症以及肝脏中葡萄糖和脂质的过量生产。胰岛素通过激活SREBP-1c的Akt和aPKC来增加脂肪酶的表达。在胰岛素抵抗状态下,该途径被过度激活。胰岛素通过Akt依赖性FoxO1和PGC-1α的磷酸化/失活抑制糖原异生酶的表达。在apkC过量的情况下,该途径在胰岛素抵抗状态中受损,从而使Akt脱离了脚手架蛋白WD40 / ProF,而Akt磷酸化/抑制了FoxO1。但是PGC-1α和FoxO1如何在胰岛素作用和抗药性上协调尚不确定。在这里,在正常小鼠中,我们发现胰岛素与Akt和aPKC一起通过aPKC依赖性机制增加了与WD40 / ProF的PGC-1α缔合。但是,在胰岛素抵抗性高脂喂养的小鼠中,例如FoxO1,APKC介导的Akt从WD40 / ProF的置换取代了aktc介导的Akt的置换,削弱了pGC-1α的磷酸化,因为aPKC抑制作用减弱了其与WD40 / proF的结合,同时恢复了akt与WD40 / ProF的结合以及PGC-1α和FoxO1的磷酸化/抑制。此外,在高脂喂养的小鼠中,除活性外,PGC-1α的表达不仅通过FoxO1激活而增加,而且,如在人肝细胞中发现的那样,还通过需要aPKC和SREBP-1c的机制而增加。 PKC-1的表达和活性。在高脂饮食小鼠中,抑制肝aPKC不仅恢复了与WD40 / ProF和FoxO1 /PGC-1α磷酸化相关的Akt结合,而且还减少了SREBP-1c,PGC-1α,PKC-1和糖原异生性和脂生性的表达酶,纠正​​糖耐量异常和高脂血症。结论:WD40 / ProF相关的Akt通过协同失活FoxO1和PGC-1α来促进胰岛素抑制糖异生酶的表达。但是这种协调也增加了对aPKC过度活跃的脆弱性,这是由SREBP-1c诱导的PGC-1α和PKC-1的增加所诱使的。

更新日期:2017-12-18
down
wechat
bug